Form 6-K AnPac Bio-Medical Scienc For: Oct 03
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of October 2022
Commission File Number: 001-39137
AnPac Bio-Medical Science Co., Ltd.
801 Bixing Street, Bihu County
Lishui, Zhejiang Province 323006
The People’s Republic of China
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x | Form 40-F ¨ |
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
EXPLANATORY NOTE
Amendments to Articles of Incorporation or Bylaws
AnPac Bio-Medical Science Co., Ltd. has adopted the Fourth Amended and Restated Memorandum and Articles of Association on May 19, 2022. The full text of the Fourth Amended and Restated Memorandum and Articles of Association is set forth in Exhibit 5.03 to this report
EXHIBIT INDEX
Exhibit | Description | |
5.03 | Fourth Amended and Restated Memorandum and Articles of Association |
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
AnPac Bio-Medical Science Co., Ltd. | |||
By: | /s/ Dr. Chris Chang Yu | ||
Name: | Dr. Chris Chang Yu | ||
Title: | Co-Chairman of the Board of Directors and Co-Chief Executive Officer |
Dated: October 3, 2022
ATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Clorox to Present at Goldman Sachs Global Staples Forum
- Trulioo 24/7 Support Empowers Top APAC Region Companies to Expand Into New Markets, Achieve Compliance and Accelerate Customer Onboarding
- Centessa Pharmaceuticals Announces Pricing of $100 Million Public Offering of American Depositary Shares
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!